Rivaroxaban versus standard anticoagulation for symptomatic venous thromboembolism (REMOTEV observational study): Analysis of 6-month outcomes-Reference-Cited by-同舟云学术

Rivaroxaban versus standard anticoagulation for symptomatic venous thromboembolism (REMOTEV observational study): Analysis of 6-month outcomes

Published:2017-01 Issue: Volume:226 Page:103-109
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Gaertner Sébastien,Cordeanu Elena-Mihaela,Nouri Salah,Faller Alix-Marie,Frantz Anne-Sophie,Mirea Corina,Bilbault Pascal,Ohlmann Patrick,Le Ray Isabelle,Stephan Dominique

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference27 articles.

1. Antithrombotic therapy for VTE disease. Chest guideline and expert panel report;Kearon;Chest,2016

2. Dabigatran versus warfarin in the treatment of acute venous thromboembolism;Schulman;N. Engl. J. Med.,2009

3. Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis;Schulman;Circulation,2014

4. Oral rivaroxaban for symptomatic venous thromboembolism;Bauersachs;N. Engl. J. Med.,2010

5. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism;Büller;N. Engl. J. Med.,2012

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Different Anticoagulation Regimens for Deep Vein Thrombosis in Real Clinical Practice;Journal of Venous Disorders;2024

2. Safety and Efficacy of Therapeutic Anticoagulation with Subcutaneous Unfractionated Heparin in Patients with Renal Failure;Seminars in Thrombosis and Hemostasis;2023-08-23

3. A Real-World Cost-Effectiveness Analysis of Rivaroxaban versus Vitamin K Antagonists for the Treatment of Symptomatic Venous Thromboembolism: Lessons from the REMOTEV Registry;Medicina;2023-01-16

4. Risk of Bleeding Associated With Outpatient Use of Rivaroxaban in VTE Management at a National Referral Hospital in Western Kenya;Clinical and Applied Thrombosis/Hemostasis;2023-01

5. Pooled Analysis of Rivaroxaban therapy for acute venous thromboembolism in FIRST registry, SWIVTER and DRESDEN NOAC registry;Research and Practice in Thrombosis and Haemostasis;2022-10